Apple's iPhone tops smartphone charts

Apple's iPhone tops smartphone charts

Up next

Levi's frayed forecast

Levi beat on revenue and profit. (00:13) Shares fell anyway. Monster sets the date for a 2-for-1 split. (01:33) Burry bets on betting. (02:05)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers Thursday: AZN, AP, and moreSK Hynix US listing said to be over s ...  Show more

STAAR prelims signal upside

STAAR Surgical (STAA) announces preliminary net sales for first quarter 2026. (00:14) Disney (DIS) plans 1,000 job cuts in marketing overhaul under new CEO Josh D’Amaro. (01:15) Cheap semaglutide copies in India challenge Novo Nordisk, cut Eli Lilly’s lead: report. (02:07)Episode ...  Show more

Recommended Episodes

Motley Fool Money: 03.15.2013
Motley Fool Hidden Gems Investing

The Dow hits an all-time high.  Samsung unveils its latest rival to the iPhone.  And Mayor Bloomberg suffers a sweet defeat. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Apple’s Record High… And Structure Therapeutics’ CEO On Weight Loss Drugs 6/11/24
CNBC's "Fast Money"

Shares of Apple jumping to record highs just a day after falling flat on its new AI announcements. The turnaround for the tech titan, and what it means for the market. Plus The weight loss wars rage on… and we’re honing in on oral version of GLP-1’s. How one pharma stock is fa ...

  Show more

Apple is no longer an iPhone company, Under Armour’s 14% stock plummet, and beards break P&G’s Gilette
The Best One Yet

Turns out Apple is no longer an iPhone company after releasing its latest quarterly earnings report. Under Armour hasn’t embraced the athleisure trend enough and its latest 14% stock drop reveals it needs a rebrand. And P&G stock jumped 4% even though it suffered a $5.4B loss — b ...  Show more

After the Rally: Pfizer's COVID Booster vs. Omicron, Apple's Record Run, The EV Battle Intensifies and Stitch Fix Plummets
Squawk on the Street

The morning after the best day for both the S&P 500 and Nasdaq since March, Carl Quintanilla, Jim Cramer and David Faber led off the show with news out of Pfizer and BioNTech: Data shows their COVID-19 vaccine neutralized the omicron variant with three shots. The anchors discusse ...  Show more